Basic monitoring includes tracking symptom changes, watching for unexpected effects, and assessing whether the protocol continues providing benefit
Discover where current studies are uncovering potential roles for peptides in health and cellular function
Results Both at doses of 10 ng/kg and 10 g/kg, BPC-157 acts statistically equally with the active controls of both groups, with imipramine (15 mg and 30 mg) and with nialamide (20 mg and 40 mg), acting better than the control group
CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke
FDA approval costs hundreds of millions to over a billion dollars, a bet pharma only makes when there's a patent to protect
The 5 initial loading doses are usually all that is needed for long lasting protection